Targeting melanosome pH is an effective method for the treatment of oculocutaneous albinism
Grondin, S.; St. Pierre, D.; Green, D. J.; Amir, S.; Yusupova, M.; Bonica, J.; Eraslan, Z.; Wills, T.; Hunt, C.; Zhou, D.; George, A.; You, J.; Anandakumar, A.; Gross, S.; Schreiner, R.; Chen, Q.; Thomas, M. G.; Loftus, S. K.; Adams, D. R.; Wakamatsu, K.; Ito, S.; Sergouniotis, P. I.; Harris, M.; Brooks, B. P.; Zippin, J. H.
Show abstract
Oculocutaneous albinism (OCA) is a genetic condition associated with impaired visual acuity and increased skin cancer risk. When OCA is due to defects in melanosome ion transport, abnormally acidic conditions in the melanosome lumen inhibit tyrosinase, the critical pigment synthetic enzyme. Hence, a therapeutic approach that optimizes melanosome pH to increase pigment production presents a potential treatment for OCA and a method for decreasing skin cancer risk. Here, we report that reduction in sAC (ADCY10) activity via naturally occurring human variants in ADCY10 restores OCA pigmentation, and sAC inhibition increases melanin synthesis in both human and mouse OCA models. These findings demonstrate that targeting melanosome pH is an effective, previously untapped therapeutic strategy for OCA and elevated skin cancer risk.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.